Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ezetimibe + pitavastatin calcium (Dongkook Pharmaceutical)
- Development stage
- Unknown
- Lead developer
- Dongkook Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
DKF-432 is a fixed-dose combination generic drug candidate being developed by Dongkook Pharmaceutical for the treatment of dyslipidemia. It is a generic version of JW Pharmaceutical's Livalojet, combining the HMG-CoA reductase inhibitor pitavastatin calcium (4 mg) with the cholesterol absorption inhibitor ezetimibe (10 mg). Pitavastatin works by inhibiting cholesterol synthesis in the liver, while ezetimibe blocks the absorption of cholesterol in the small intestine. In August 2025, Dongkook Pharmaceutical received approval from the South Korean Ministry of Food and Drug Safety (MFDS) to conduct a bioequivalence study comparing DKF-432 to Livalojet in healthy adult volunteers.
- Other names
- ezetimibe + pitavastatinpitavastatin + ezetimibepitavastatin calcium + ezetimibe
02
Targets
HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)NPC1L1 (Niemann-pick C1-Like 1 transporter)
Beyond the preview
Go deeper on ezetimibe + pitavastatin calcium (Dongkook Pharmaceutical).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ezetimibe + pitavastatin calcium (Dongkook Pharmaceutical).